Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,708.60
Bid: 1,708.40
Ask: 1,708.80
Change: 3.40 (0.20%)
Spread: 0.40 (0.023%)
Open: 1,701.60
High: 1,713.00
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Health News Summary

Thu, 29th Mar 2018 13:56

Following is a summary of current health news briefs.

Less heart disease, stroke in immigrants than in U.S.-born

People living in the U.S. but born elsewhere may have lowerrisk for heart disease and stroke than their native-bornneighbors, suggests a new study. Foreign-born residents had arange of risks, however. Women from Europe and men from Africaor South America had the lowest stroke rates compared toU.S.-born peers. Heart disease rates were lowest among men andwomen from Asia, the Caribbean, Central America and Mexico andhighest among men from the Indian Subcontinent and Europe.

First women's yoga training center opens doors in Gaza

A small group of Palestinian women in Gaza are stretchingtheir limbs with yoga to help them teach others to cope with thestresses and traumas of living in the embattled territory. TheGaza Strip, which is dominated by the Islamist Hamas faction,has experienced three wars with neighboring Israel in the past11 years.

Happiness 101: Psychology course strikes chord with Yalestudents

The search for life's sweetest but most elusive treasure -happiness - brings nearly 1,200 Yale University undergraduatestwice a week into an enormous hall on the Connecticut school'scampus for its most popular class ever. "Psychology and the GoodLife" is such a hit that one in four undergraduate students atthe Ivy League university is enrolled in the spring semestercourse, said Laurie Santos, the psychology professor who teachesthe class. It is the largest class enrollment size in thehistory of Yale, founded in 1701.

Teva wins reversal of U.S. jury's $235 million GSK drugpatent verdict

A federal judge on Wednesday overturned a U.S. jury'sverdict that required Teva Pharmaceutical Industries Ltdto pay GlaxoSmithKline Plc more than $235million for infringing a patent covering its blood pressure drugCoreg. U.S. District Judge Leonard Stark in Wilmington, Delawareruled that the evidence did not support the jury's finding inJune that Teva sales of a generic version of the drug causeddoctors to infringe GSK's patent.

Childhood cancer survivors may develop heart problems sooner

Adult survivors of childhood cancer have a greater risk ofheart disease and develop risk factors like high blood pressureand elevated cholesterol earlier in life compared to the generalpopulation, a German study suggests. Researchers studied 951adults, ages 23 to 48, who had been diagnosed with cancer whenthey were less than 15 years old. The study team looked at labtests for risk factors for heart disease, and also forconditions like heart failure, stroke and heart attacks. Alongwith the cancer survivors, they studied more than 15,000similar people who didn’t have malignancies as children.

Ireland sets abortion referendum date for May 25

Ireland will hold a referendum on May 25 on whether or notto liberalize its abortion law, the first opportunity in 35years to overhaul one of the world's strictest regimes that haslong divided the once deeply Catholic nation. A complete ban onabortion was only lifted five years ago for cases where themother's life was in danger. That move fueled calls to givevoters under the age of 50 their first say on more comprehensivereform.

Colon cancer screening rates vary widely across U.S.

The proportion of U.S. adults who get recommended coloncancer screenings has never been as high as doctors would like,but a new study suggests that it’s much lower than expected insome pockets of the country. To catch colon cancer early, whenit’s easier to treat and less lethal, physicians typicallyrecommend that adults aged 50 to 75 get screened every 10 yearswith a colonoscopy or annually with fecal tests. Nationwide,only about 67 percent of adults in this age range were currentwith screening, the study found.

FDA working on a 'dozen' policies to boost copycat biotechdrugs

The U.S. Food & Drug Administration is working on around adozen actions to boost use of cheaper versions of expensivebiotech medicines, the head of the agency Scott Gottlieb said onWednesday. The United States has lagged behind Europe in use ofso-called biosimilars, to the frustration of FDA policymakerswho are starting to approve such products but who are seeingother impediments to getting them to consumers.

Listeria class action filed against South Africa's TigerBrands

A class action lawsuit was filed on Thursday against SouthAfrica's Tiger Brands, after one of its food factorieswas linked to a listeria outbreak that has killed 180 peoplesince early 2017, the lawyer running the case said. RichardSpoor, a human rights advocate who previously masterminded amassive class action on behalf of gold miners with silicosis,filed the lawsuit on behalf of families affected by the listeriaoutbreak. The case against Tiger Brands was clear, Spoor said.

Pregnant? Warm weather exercise and hot baths might be okay

Pregnant women who exercise outside on warm days or spend alittle time in a hot bath or sauna may not necessarily raisetheir body temperature enough to cause problems, a researchreview suggests. While most women without health problems cansafely exercise during pregnancy, doctors discourage workouts inhot weather because it can lead to heat stress and dehydration.Physicians also advise women to avoid saunas and hot tubsbecause these activities can raise the body temperature andincrease the risk of birth defects.

More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.